Decision

27 February 2019: Galderma UK (Ltd) Website

Updated 11 June 2019

MHRA received an anonymous complaint from a health care professional about Galderma UK’s website. The complainant alleged that the website potentially promoted prescription only medicines to the public by not including measures to differentiate between healthcare professional and public viewers which would allow them to provide material appropriate for each audience. The complainant also alleged that links to medicines’ Summary of Product Characteristics were broken and that other content may be out of date on the basis of the stated date of preparation.

Galderma confirmed that they had immediately replaced the website with a holding page while undertaking a review of the content and making any necessary changes.